The US biotech is hoping to either partner off its wholly owned pipeline or become a target for an acquisition or merger after AstraZeneca’s asthma exit left it with dwindling cash, and a need to cut costs.

Rising leader Mårten Steen, spoke with In Vivo about translating science into business, building precision medicine firms from the ground up and the importance of high-energy leadership.

Pfizer and BioNTech's COVID-19 vaccine picks up its third emergency authorization, with all eyes now on the final decision from the US FDA. Elsewhere, there are changes at the UK's vaccine taskforce, while Korea is moving ahead with vaccine development plans.  

Our monthly update on technology transfer deals--licensing agreements between companies and universities or other research institutions--in the fields of life sciences, including pharmaceuticals, medical devices, in vitro diagnostics and research/analytical instrumentation and reagents.